Bristol-Myers Squibb Co (BMY) is Doyle Wealth Management's 8th Largest Position


Doyle Wealth Management raised its position in Bristol-Myers Squibb Co by 3.6% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 308,942 shares of the biopharmaceutical company's stock after buying an additional 10,743 shares during the period.



from Biotech News